Answer
After AdreView (iobenguane-123I) administration, breastfeeding must be interrupted for three days and expressed feeds discarded, with breastfeeding restarted only when milk radioactivity will not result in a radiation dose greater than 1 mSv to the child.
Sources for this answer
- AdreView 74 MBq/mL Solution for InjectionGE Healthcare Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked